We are pleased to announce the official release of the Android version of the FLD app, which has been uniquely developed by our company after years of foundational research. The FLD app allows for completely non-contact, non-invasive simultaneous measurement of HbA1c (Hemoglobin A1c), pulse rate, and oxygen saturation in a short time (approximately 10 seconds). …
Read more “The release of the FLD app for Android has commenced.”
We are pleased to announce that the release date has been finalized for the Android version of the FLD app, which we have developed after years of fundamental research. The release date is set for Sunday, September 21, 2025. The app will be available for download from our SFM App Store. Further information, including details …
Read more ““Regarding the Release Date of the FLD App for Android””
We are pleased to inform you that we have finalized the recommended and compatible devices for the Android version of the FLD app, which allows for simultaneous non-contact, non-invasive measurement of HbA1c, pulse, and oxygen saturation. The recommended devices are as follows: Additionally, the app is also compatible with Sony Xperia series models released from …
Read more “Regarding the Recommended and Compatible Devices for the FLD App for Android”
Our company has entered into a special agreement with the University of Tokyo. As reported in our previous press release, the Institute for Quantitative Biosciences at the University of Tokyo (hereinafter referred to as “IQB”) and our company have jointly developed, implemented, and advanced unique security equipment known as the “IQB Gate.” This initiative has …
Recently, we received a request to provide additional information regarding the 72nd Annual Scientific Meeting of the Japanese Society of Laboratory Medicine (National Conference) held from August 28 to August 31, 2025, as mentioned earlier. Therefore, we would like to present further details as follows. Venue: Makuhari Messe International Conference Hall Presentation Date and Time: …
Read more “[Follow-up Report] Announcement Regarding the Presentation at the Medical Conference”
We are pleased to announce an expansion in the range of compatible devices for the Android version of the FLD app, whose development we recently completed. In our recent press release, we had stated that the app was currently available for use on Samsung’s Galaxy series devices. We are now delighted to inform you that …
Read more “Regarding the Expansion of Supported Devices for the FLD App for Android”
We are pleased to announce that the development of the Android version of FLDApp has been completed. This application enables simultaneous, non-contact, non-invasive short-term (approximately 10 seconds) measurements of HbA1c, oxygen saturation, and pulse rate. It will first be released on Samsung’s Galaxy series (the range of supported devices is expected to expand). The decision …
Read more “Regarding the Completion of the FLD App Development for Android”
I am pleased to report that yesterday, a presentation regarding our company’s non-contact and non-invasive biomarker technology was delivered at the prestigious National Medical Association Conference. This presentation has allowed our technology to gain academic validation, elevating it to a more reliable and trustworthy level. However, our company remains committed to pursuing more advanced and …
Read more “Regarding the Presentation at the Medical Conference”
The “Smartphone Software Competition Promotion Act” (hereinafter referred to as the “New Smartphone Law”), which aims to rectify the monopolistic state of major platform operators and promote fair competition, will come into effect in Japan on December 18, 2025. Our development of the “SFM App Store” for Android is nearly complete, and we will be …
We are pleased to announce that the development of the Android version of the FLD App is progressing, and we plan to release it in September 2025, targeting Samsung’s Galaxy models (with specified recommended models). Similar to the iOS version, the FLD App will enable the measurement of HbA1c, oxygen saturation, and pulse rate. Starting …